EGFR and urinary bladder carcinoma: By applying an expression signature from highly invasive bladder cancer cells and the respective regulatory core, our model predicted resistance to EGFR inhibition in cells overexpressing E2F1. Indeed, treatment of UM-UC-3 with EGFR inhibitors resulted only in a marginal reduction of cell invasion.